1457 related articles for article (PubMed ID: 19955044)
1. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
2. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
3. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
5. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
7. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
[TBL] [Abstract][Full Text] [Related]
9. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
12. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
13. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
[TBL] [Abstract][Full Text] [Related]
14. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR
J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
[TBL] [Abstract][Full Text] [Related]
15. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
[TBL] [Abstract][Full Text] [Related]
17. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
20. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
